{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T16:12:25Z","timestamp":1699978345358},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1007\/bf02893486","type":"journal-article","created":{"date-parts":[[2009,1,9]],"date-time":"2009-01-09T23:09:32Z","timestamp":1231542572000},"page":"114-122","source":"Crossref","is-referenced-by-count":2,"title":["Lineage-specific clonality analysis of chronic myeloproliferative disorders and myelodysplastic syndrome by human androgen receptor assay"],"prefix":"10.1007","volume":"13","author":[{"given":"P\u00e1l","family":"J\u00e1ks\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Kereskai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenke","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Pajor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02893486_CR1","first-page":"1229","volume":"51","author":"RC Allen","year":"1992","unstructured":"Allen RC, Zoghbi HY, Moseley AB: Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51:1229\u20131239, 1992","journal-title":"Am J Hum Genet"},{"key":"BF02893486_CR2","unstructured":"Anderson JE, Gilliland DG, List AF: Myelodysplastic syndrome. Educational Materials by the American Society of Hematology, 1998"},{"key":"BF02893486_CR3","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ: Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365:1054\u20131061, 2005","journal-title":"Lancet"},{"key":"BF02893486_CR4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.leu.2400936","volume":"12","author":"L Busque","year":"1990","unstructured":"Busque L, Gilliland DG: X-inactivation analysis in the 1990s: promise and potential problems. Leukemia 12:128\u2013135, 1998","journal-title":"Leukemia"},{"key":"BF02893486_CR5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2141.1992.tb08238.x","volume":"81","author":"DJ Culligan","year":"1992","unstructured":"Culligan DJ, Cachia P, Wittaker J: Clonal lymphocytes are detectable in only some cases of MDS. Br J Haematol 81:346\u2013352, 1992","journal-title":"Br J Haematol"},{"key":"BF02893486_CR6","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM199905273402107","volume":"340","author":"ML Heaney","year":"1999","unstructured":"Heaney ML, Golde DW: Myelodysplasia. N Engl J Med 340:1649\u20131660, 1999","journal-title":"N Engl J Med"},{"key":"BF02893486_CR7","doi-asserted-by":"crossref","unstructured":"Hellstr\u00f6m-Lindberg E, Willmann C, Barrett AJ: Achievements in understanding and treatment of myelodysplastic syndromes. Educational Materials by the American Society of Hematology, 2000.","DOI":"10.1182\/asheducation-2000.1.110"},{"key":"BF02893486_CR8","series-title":"World Health Organization Classification of Tumours","volume-title":"Pathology & Genetics, Tumours of Haematopoietic and Lymphoid Tissues","year":"2001","unstructured":"Jaffe ES, Harris NL, Stein H, Vardinian JW eds. World Health Organization Classification of Tumours, Pathology & Genetics, Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2001"},{"key":"BF02893486_CR9","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James C, Ugo V Le Couedic JP: A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434:1144\u20131148, 2005","journal-title":"Nature"},{"key":"BF02893486_CR10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/gcc.2870100204","volume":"10","author":"S Knuutila","year":"1994","unstructured":"Knuutila S, Teerenhovi L, Larramendy ML: Cell lineage involvement of recurrent chromosomal abnormalities in hematological neoplasms. Genes, Chromosomes Cancer 10:95\u2013102, 1994","journal-title":"Genes, Chromosomes Cancer"},{"key":"BF02893486_CR11","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Passamonti F, Buser AS: A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352:1779\u20131790, 2005","journal-title":"N Engl J Med"},{"key":"BF02893486_CR12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","volume":"7","author":"RL Levine","year":"2005","unstructured":"Levine RL, Wadleigh M, Cools J: Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocytemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7:387\u2013397, 2005","journal-title":"Cancer Cell"},{"key":"BF02893486_CR13","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood.V96.6.2012","volume":"156","author":"L Nilsson","year":"2000","unstructured":"Nilsson L, \u212bstrand-Grundstr\u00f6m I: Isolation and characterization of hematopoietic progenitor\/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level. Blood 156:2012\u20132021, 2000","journal-title":"Blood"},{"key":"BF02893486_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0145-2126(97)00131-8","volume":"22","author":"L Pajor","year":"1998","unstructured":"Pajor L, Matolcsy A, Vass JA, M\u00e9hes G, Marton \u00c9, Szab\u00f3 F: Phenotypic and genotypic analyses of blastic cell population suggest that pure B-lymphoblastic leukemia may arise from myelodysplastic syndrome. Leuk Res 22:13\u201317, 1998","journal-title":"Leuk Res"},{"key":"BF02893486_CR15","doi-asserted-by":"crossref","unstructured":"Pearson TC, Messinezy M, Westwood N: A Polycythemia Vera Update: diagnosis, pathobiology, and treatment. Educational Materials by the American Society of Hematology, 2000.","DOI":"10.1182\/asheducation-2000.1.51"},{"key":"BF02893486_CR16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/sj.leu.2400934","volume":"12","author":"WH Raskind","year":"1998","unstructured":"Raskind WH, Steinmann L, Najfeld V: Clonal development of myeloproliferative disorders: clues to hematopoietic differentiation and multistep pathogenesis of cancer. Leukemia 12: 108\u2013116, 1998","journal-title":"Leukemia"},{"key":"BF02893486_CR17","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1046\/j.1365-2141.1998.00867.x","volume":"102","author":"L Tonon","year":"1998","unstructured":"Tonon L, Bergamaschi G, Dellavecchia C, Rosti V, Lucotti C, Malabarba: Unbalanced X-chromosome inactivation in haematopoietic cells from normal women. Br J Haematol 102:996\u20131003, 1998","journal-title":"Br J Haematol"},{"key":"BF02893486_CR18","doi-asserted-by":"crossref","first-page":"22788","DOI":"10.1074\/jbc.C500138200","volume":"280","author":"R Zhao","year":"2005","unstructured":"Zhao R, Xing S, Li Z: Identification of an acquired JAK2 mutation in Polycythemia vera. J Biol Chem 280:22788\u201322792, 2005","journal-title":"J Biol Chem"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02893486.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02893486\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02893486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T14:39:09Z","timestamp":1589467149000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02893486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["BF02893486"],"URL":"https:\/\/doi.org\/10.1007\/bf02893486","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}